Palogic Value Management’s Freeport-McMoran FCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.57M Buy
24,952
+106
+0.4% +$6.81K 0.52% 39
2026
Q1
$1.46M Buy
24,846
+239
+1% +$14.4K 0.62% 43
2025
Q4
$1.25M Buy
24,607
+660
+3% +$28.6K 0.52% 59
2025
Q3
$939K Buy
23,947
+276
+1% +$12K 0.38% 77
2025
Q2
$1.03M Buy
23,671
+102
+0.4% +$3.87K 0.42% 73
2025
Q1
$892K Buy
23,569
+3,292
+16% +$126K 0.39% 82
2024
Q4
$772K Buy
20,277
+292
+1% +$13.1K 0.29% 92
2024
Q3
$998K Buy
19,985
+386
+2% +$17.4K 0.34% 83
2024
Q2
$953K Buy
19,599
+535
+3% +$27K 0.4% 79
2024
Q1
$896K Buy
19,064
+1,108
+6% +$44.7K 0.39% 82
2023
Q4
$764K Buy
17,956
+2,038
+13% +$75.3K 0.34% 82
2023
Q3
$594K Buy
15,918
+296
+2% +$11.9K 0.28% 91
2023
Q2
$625K Buy
15,622
+1,030
+7% +$39.3K 0.29% 90
2023
Q1
$597K Buy
14,592
+1,571
+12% +$65.3K 0.29% 87
2022
Q4
$495K Buy
+13,021
New +$455K 0.26% 95

Other funds holding FCX

Palogic Value Management's FCX Position: Q2 2026 in Review

Palogic Value Management increased its Freeport-McMoran (FCX) stake by 0.43% in Q2 2026, buying an estimated $6.81K and bringing the position to 24,952 shares worth $1.57M. The position accounts for 0.52% of the portfolio, ranked #39.

Palogic Value Management first reported a position in FCX in Q4 2022 and has held it in 15 quarters since. 1,888 funds tracked by Wall St. Rank hold FCX as of Q2 2026.

  • Palogic Value Management held 24,952 shares of Freeport-McMoran worth $1.57M as of Q2 2026.
  • Palogic Value Management bought 106 Freeport-McMoran shares in Q2 2026, an estimated $6.81K.
  • Freeport-McMoran made up 0.52% of Palogic Value Management's portfolio in Q2 2026, its #39 holding.
  • Palogic Value Management first reported a position in Freeport-McMoran in Q4 2022 and has held it in 15 quarters since.
  • 1,888 funds tracked by Wall St. Rank held Freeport-McMoran as of Q2 2026.

Based on Palogic Value Management's 13F filing for Q2 2026, filed 14 Aug 2026.